Vanda Pharmaceuticals

Yahoo Finance • 4 days ago

Sector Update: Health Care Stocks Mixed Late Afternoon

Health care stocks were mixed late Thursday afternoon, with the NYSE Health Care Index adding 0.1% a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 days ago

Sector Update: Health Care Stocks Advance in Afternoon Trading

Health care stocks advanced Thursday afternoon, with the NYSE Health Care Index adding 0.3% and the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 2 months ago

Vanda Pharmaceuticals price target raised to $17 from $14 at B. Riley

B. Riley raised the firm’s price target on Vanda Pharmaceuticals (VNDA) to $17 from $14 and keeps a Buy rating on the shares. Following BYSANTI’s approval, the firm’s revenue model for Vanda has been updated, reflecting expected growth in... Full story

Yahoo Finance • 2 months ago

FDA Accepts Vanda's BLA For Imsidolimab In Generalized Pustular Psoriasis

(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) on Wednesday said the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for imsidolimab for the treatment of Generalized Pustular Psoriasis (GPP), a r... Full story

Yahoo Finance • 2 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Vanda Pharmaceuticals Inc. (“Vanda” or the “Company”) (NASDAQ: VNDA).  Such investors are advised to contact Danielle Peyton at... Full story

Yahoo Finance • 3 months ago

Stocks Decline as Chip Makers and Data Storage Companies Fall

The S&P 500 Index ($SPX) (SPY) today is down -0.33%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.35%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.34%.  March E-mini S&P futures (ESH26) are down -0.35%, and March E-mini N... Full story

Yahoo Finance • 3 months ago

Stocks making the biggest moves midday: Nike, Corcept Therapeutics, Taiwan Semiconductor & more

Check out the companies making the biggest moves midday: Nike — Shares of the sneaker giant rose around 4% after board members Tim Cook and Robert Holmes Swan, as well as Nike CEO Elliott Hill, increased their stakes, Verity data shows. Th... Full story

Yahoo Finance • 3 months ago

Stocks Slide on Weakness in Megacap Tech Stocks

The S&P 500 Index ($SPX) (SPY) today is down -0.15%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.18%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.19%.  March E-mini S&P futures (ESH26) are down -0.17%, and March E-mini N... Full story

Yahoo Finance • 3 months ago

Vanda Jumps 21% After FDA Approves Motion Sickness Therapy

This article first appeared on GuruFocus. Vanda Pharmaceuticals (NASDAQ:VNDA) jumped roughly 21% in premarket trading after the U.S. Food and Drug Administration approved its motion sickness therapy Nereus, also known as tradipitant, a dr... Full story

Yahoo Finance • 3 months ago

Biggest stock movers Wednesday: Vanda Pharmaceuticals and Cybin

[Market Movers Stock Market Ticker Words 3d Illustration] iQoncept U.S. stock futures edged lower on Wednesday, the final trading day of 2025, extending a three-session losing streak for major U.S. benchmarks. Here are some of Wednesday'... Full story

Yahoo Finance • 3 months ago

Trending tickers: Nvidia, Caterpillar, Vanda Pharmaceuticals and Walker Crips

Nvidia (NVDA) Shares in Nvidia fell in pre-market trading on Wednesday despite reports that the chipmaker is scrambling to meet strong demand from Chinese technology groups for its H200 AI chips and has approached TSMC (TSM) to ramp up pr... Full story

Yahoo Finance • 3 months ago

3 Biotech Stocks With Major 2026 Catalysts

The biotech sector staged a robust comeback in 2025, with the Nasdaq Biotechnology Index climbing 33.8%. Although concerns about potential high tariffs initially hurt the industry, sentiment among investors rebounded sharply, powering a no... Full story

Yahoo Finance • 4 months ago

Healthcare & Biotech Stocks Rally After Hours: Sensei, Praxis, Cooper, Vanda, Cue, ResMed

(RTTNews) - Several healthcare and biotech names posted notable gains in Thursday's after-hours session, driven by clinical updates, earnings results, and regulatory developments. Sensei Biotherapeutics Inc. (SNSE) soared 62.9% to $17.20... Full story

Yahoo Finance • 4 months ago

Vanda jumps as FDA lifts tradipitant partial clinical hold

[FDA Headquarters] * Vanda Pharmaceuticals (VNDA [https://seekingalpha.com/symbol/VNDA]) has surged ~7% in after-hours trading Thursday after the US FDA lifted its partial clinical hold on tradipitant for motion sickness. * The drugma... Full story

Yahoo Finance • 4 months ago

FDA re-review of Vanda tradipitant partial clinical hold extended

[FDA Headquarters] * The US FDA is extending by a matter of days a re-review of a partial clinical hold on long-term studies of Vanda Pharmaceuticals' (VNDA [https://seekingalpha.com/symbol/VNDA]) tradipitant for motion sickness. * Th... Full story

Yahoo Finance • 5 months ago

Vanda Pharmaceuticals Surges 21% After Positive Tradipitant Trial In GLP-1 Adjunct Setting

(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) jumped 21.02% to $5.32, up $0.92, after announcing positive topline results from its phase III study of tradipitant in preventing nausea and vomiting induced by GLP-1 agonists in overweight and... Full story

Yahoo Finance • 5 months ago

Vanda's tradipitant can significantly reduce nausea in those taking a GLP-1

[Curvy woman feeling nauseous having stomach ache] Antonio_Diaz/iStock via Getty Images * A phase 2 trial of Vanda Pharmaceuticals' (VNDA [https://seekingalpha.com/symbol/VNDA]) tradipitant found that the oral therapy tradipitant signif... Full story

Yahoo Finance • 5 months ago

Jim Cramer on Vanda Pharmaceuticals: “I’m Going to Bless That One as Your Spec”

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) is one of the stocks on Jim Cramer’s radar recently. When Cramer was asked about the stock toward the end of the lightning round, he said: “Well, look, here’s the way I feel about Vanda. This is a... Full story

Yahoo Finance • 6 months ago

Monumental Sports & Entertainment Taps D.C.'s Own Vanda Pharmaceuticals as Founding Partner to Help Drive the Creation of Brand-New Downtown Arena

Multiyear agreement includes exclusive Monumental Sports Network studio entitlement, activations across Capitals, Wizards, and Mystics, and deep integration via community and media platforms For photos of the new Vanda Pharmaceuticals Stu... Full story

Yahoo Finance • 7 months ago

US High Growth Tech Stocks to Watch This August 2025

As of August 2025, the U.S. stock market is experiencing a remarkable upswing, with key indices like the S&P 500 and Dow Jones Industrial Average reaching record highs amid anticipation of a significant inflation report. In this thriving e... Full story